Antifibrotic role of low-dose mitomycin-c-induced cellular senescence in trabeculectomy models.
<h4>Purpose</h4>We assessed whether mitomycin-C (MMC) has different antifibrotic mechanisms in trabeculectomy wound healing.<h4>Methods</h4>We identified 2 concentrations of MMC as "low-dose" by using WST-1 assay, Lactic dehydrogenase assay, and fluorescence-activat...
Main Authors: | Le-Tien Lin, Jiann-Torng Chen, Da-Wen Lu, Ming-Cheng Tai, Chang-Min Liang, Ching-Long Chen, Shu-I Pao, Chih-Kang Hsu, Yi-Hao Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0234706 |
Similar Items
-
The safety and efficacy of minimal dose of mitomycin C in trabeculectomy
by: Rekha Bellulli Kotrappa, et al.
Published: (2016-01-01) -
Surgical outcomes of repeat trabeculectomy augmented with high dose mitomycin C
by: Sharmila Rajendrababu, et al.
Published: (2019-01-01) -
Mitomycin C in Trabeculectomy and Macular Thickness
by: Halit Oğuz
Published: (2012-12-01) -
Trabeculectomy combined with mitomycin and retinal condensation for neovascular glaucoma
by: Yue-Sheng Qiu, et al.
Published: (2016-04-01) -
Clinical observation of glaucoma trabeculectomy with mitomycin C treatment
by: Shi Liu, et al.
Published: (2014-12-01)